The influence of chemical structure of phosphonic acids labeled with gallium-68 on their pharmacokinetic properties in animals
Authors:
- V M PetrievVPV M Petriev
- V K TishchenkoVTV K Tishchenko
- A A MikhailovskayaAMA A Mikhailovskaya
- E D StepchenkovaESE D Stepchenkova
- K A KuzenkovaKKK A Kuzenkova
- A A PostnovAPA A Postnov
- I N ZavestovskayaIZI N Zavestovskaya
Open Access
- 1 January 2020
- conference paper
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1439 (1)
Abstract
68 Ga-labeled phosphonates are of great interest due to their possibility to serve promising agents in nuclear medicine for bone tissue PET imaging. It is known that multidentate aminophosphonate ligands could form much stable chelates with different radiometals as compared to diphosphonates. In this work we studied the pharmacokinetic properties of 68Ga-labeled complexes with two, four and five phosphonate groups (68Ga-HEDP, 68Ga-EDTMP, and 68Ga-DTPMP, respectively) in normal Wistar rats after intravenous administration. It was shown that the structure of phosphonates had a great influence on the biodistribution of 68Ga-HEDP, 68Ga-EDTMP, and 68Ga-DTPMP. Complexes with higher number of aminomethylenephosphonate groups (68Ga-EDTMP and 68Ga-DTPMP) had higher bone uptake than diphosphonate 68Ga-HEDP. In blood 68Ga-HEDP had lower activity than 68Ga-EDTMP and 68Ga-DTPMP, indicating poor stability of diphosphonate-based complex. In other soft organs and tissues 68Ga-EDTMP and 68Ga-DTPMP uptake was slightly lower as compared with 68Ga-HEDP. In conclusion, 68Ga-EDTMP and 68Ga-DTPMP have the potential to be suitable radiotracers for bone tissue PET imaging.Keywords
This publication has 9 references indexed in Scilit:
- Radiopharmaceuticals Based on Polyaminophosphonic Acids Labeled with α−, β−, and γ-Emitting Radionuclides (Review)Pharmaceutical Chemistry Journal, 2015
- Absorption, distribution and excretion of intravenously injected 68Ge/68Ga generator eluate in healthy rats, and estimation of human radiation dosimetryEJNMMI Research, 2015
- A comparative study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and 99mTc-MDP whole-body bone scanning for imaging osteolytic bone metastasesBMC Medical Imaging, 2015
- 68Ga-DOTA and analogs: Current status and future perspectivesReports of Practical Oncology and Radiotherapy, 2014
- Prospective of 68Ga-Radiopharmaceutical DevelopmentTheranostics, 2014
- 68Ga-BPAMD: PET-imaging of bone metastases with a generator based positron emitterNuclear Medicine and Biology, 2012
- Phosphonates, their complexes and bio-applications: A spectrum of surprising diversityCoordination Chemistry Reviews, 2012
- The role of FDG‐PET/CT in suspected recurrence of breast cancerCancer, 2006
- Skeletal complications of malignancyCancer, 1997